In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells
article
OA: closed
CC0
⤵ 27 in-corpus citations
AI-generated summary
This study investigated the effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells in vitro.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo investigate the in vitro effects of atorvastatin on lipopolysaccharide (LPS)-induced gene expression in endometrial-endometriotic stromal cells.DesignIn vitro experimental study using flow cytometry, ELISA, semiquantitative reverse transcriptase polymerase chain reaction, and Western blot.SettingPostgraduate Institute of Medical Education and Research.Patient(s)Twenty-five women undergoing laparoscopy (n = 10) and laparotomy (n = 15).Intervention(s)Endometriotic cyst wall (group I) and endometrial biopsy (group II) collection.Main outcome measure(s)The endometrial-endometriotic stromal cells were isolated from ectopic (group I) and eutopic (group II) endometrium by established methods, cultured, and stimulated with LPS (1 μg/mL), followed by atorvastatin treatment in a time- and dose-dependent manner to investigate the effects of LPS on proliferation (Ki-67) and expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), receptor for advanced glycation end products (RAGE), extracellular newly identified RAGE binding protein (EN-RAGE), peroxisome proliferator activated receptor-γ (PPAR-γ), and liver X receptor-α (LXR-α) genes in endometrial-endometriotic stromal cells and on levels of insulin-like growth factor binding protein-1 (IGFBP-1) and 17β-E(2) in endometrial-endometriotic stromal cell culture supernatant.Result(s)Significant inhibition of Ki-67 and LPS-induced expression of inflammatory and angiogenic genes (COX-2, VEGF, RAGE, and EN-RAGE) was observed in atorvastatin-treated endometrial-endometriotic stromal cells. In contrast, a significant dose- and time-dependent increase in expression of anti-inflammatory genes (PPAR-γ and LXR-α) and levels of IGFBP-1 was observed after atorvastatin treatment in both the groups. However, atorvastatin treatment had no effect on 17β-E(2) levels in endometrial/endometriotic stromal cell culture supernatant.Conclusion(s)The data of the present study provide new insights for the implication of atorvastatin treatment for endometriosis in humans.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (55)
- Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells via openalex
- Diagnosis and management of endometriosis. via openalex
- Endometrial Angiogenesis, Vascular Maturation, and Lymphangiogenesis via openalex
- Endometriosis via openalex
- Endometriosis and Inflammation in Infertility via openalex
- Expression of Glycodelin and Cyclooxygenase‐2 in Human Endometrial Tissue Following Three‐dimensional Culture via openalex
- High-dose atorvastatin causes regression of endometriotic implants: a rat model via openalex
- Inflammation in Reproductive Disorders via openalex
- Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis via openalex
- Nuclear Peroxisome Proliferator-Activated Receptors α and γ Have Opposing Effects on Monocyte Chemotaxis in Endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of 8-iso-prostaglandin F2α and 25-hydroxycholesterol in the pathophysiology of endometriosis via openalex
- Statins Inhibit Growth of Human Endometrial Stromal Cells Independently of Cholesterol Availability1 via openalex
- Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- What is the optimal medical management of infertility and minor endometriosis?: Analysis and future prospects via openalex
- W2035227348 via openalex
- W2041563335 via openalex
- W2052583421 via openalex
- W2062605111 via openalex
- W2109525253 via openalex
- W2123274778 via openalex
- W2128984725 via openalex
- W2136879631 via openalex
- W2153278559 via openalex
- W2158028016 via openalex
- W2159339965 via openalex
- W2163678936 via openalex
- W2182214562 via openalex
- W2417625587 via openalex
- W2426599902 via openalex
- W4235209420 via openalex
- W4240908764 via openalex
- W6604638086 via openalex
- W6608139517 via openalex
- W6645831435 via openalex
- W6651953250 via openalex
- W6686265676 via openalex
- W112648714 via openalex
- W6717151192 via openalex
- W1514451895 via openalex
- W1534530371 via openalex
- W1964923339 via openalex
- W1971242943 via openalex
- W1981689863 via openalex
- W1982977002 via openalex
- W1984508574 via openalex
- W2001822779 via openalex
- W2006340617 via openalex
- W2017247290 via openalex
- W2018923286 via openalex
- W2020983524 via openalex
- W2027604422 via openalex
- W2030849425 via openalex
- W2032287818 via openalex
Cited by (27)
- The role of peroxisome proliferator-activated receptors in endometriosis 2024
- Immunotherapy: A promising novel endometriosis therapy 2023
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Endometriosis and cardiovascular disease 2022
- Medical treatments of endometriosis: a review 2022
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Advances in the medical treatment of adolescent endometriosis 2021
- Use of immunomodulators to treat endometriosis 2019
- Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells 2018
- Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence 2018
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis 2018
- Medical and Surgical Management of Endometriosis 2018
- Medical Management of Endometriosis 2017
- New developments in the medical treatment of endometriosis 2017
- Effect of simvastatin on baboon endometriosis† 2017
- Novel Medical Treatment Modalities of Endometriosis 2015
- Non‐hormonal targets underlying endometriosis: A focus on molecular mechanisms 2015
- Statins as Targeted “Magical Pills” for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the “Dark Side of the Same Coin”? A Systematic Review of Literature 2015
- Comparing the Serum Lipid Profile Levels in Women Suffering From Endometriosis With Healthy Women 2014
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Effects of Simvastatin on Retinoic Acid System in Primary Human Endometrial Stromal Cells and in a Chimeric Model of Human Endometriosis 2013
- Angiogenesis and Endometriosis 2013
- Simvastatin Decreases Invasiveness of Human Endometrial Stromal Cells1 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- Novel Therapies Targeting Endometriosis 2011
- Simvastatin Induces Apoptosis and Alters Cytoskeleton in Endometrial Stromal Cells 2010
Source provenance
- europepmc
- last seen: 2026-08-29T06:12:09.280863+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:53.633898+00:00
License: CC0
· commercial use OK